CCL5 and neoplasm: Likewise, in an experimental melanoma model, tumor-infiltrating Tregs expressed CCR5 and preferentially migrated toward its ligands CCL3, CCL4, and CCL5, which were elaborated by tumor-infiltrating myeloid-derived suppressor cells (MDSCs) (82).